摘要
目的 :探讨氯沙坦逆转心血管肥厚的作用与心血管局部组织中内皮素 (ET)的关系。方法 :1 6周龄的自发性高血压大鼠 (SHR)随机分成氯沙坦治疗组 (SHR L)与对照组 (SHR C)。另设同源正常血压大鼠 (WKY)组 ,饲养共 6周。大鼠的收缩压和心率用尾套法测量 ,左室重量指数 (LVI)及主动脉中膜与内径比率用测微计测量 ,血浆、心肌和主动脉含量用放免法测定。以SHR C组做直线相关分析。结果 :氯沙坦能显著降低SHR的收缩压 ,SHR L与SHR C组比较LVI及主动脉中膜与内径比值下降 ,左室及主动脉ET ,SHR C组高于WKY组 ,且分别与LVI及主动脉中膜和内径比值呈正相关。结论 :左室及主动脉组织中ET升高是造成左室及主动脉肥厚的重要因素 。
Objective:To investigate the effect of losartan on reversing cardiovascular hypertrophy and ET contents.Methods:16 week old SHR were divided into two groups:SHR L(treated with losartan) and SHR C(untreated).Aged matched Wistar Kyoto(WKY) rats were served as controls.All rats were observed for 6 weeks. Systolic blood pressure and heart rate were measured by a tail cuff method.Left ventricular mass index(LVI) and aortic media/lumen ratio were measured as the indicators of left ventricular and aortic hypertrophy.ET contents were determined by radioimmunoassay.Results:Losartan significantly lowered systolic blood pressure.LVI and aortic media/lumen ratio were reduced in SHR L compared with SHR C.Left ventricular and aortic ET were higher in SHR C than WKY and positively correlated with LVI and aortic media/lumen respectively.Conclusion:The locally increased ET may contribute to the cardiovascular hypertrophy and losartan reverse cardiovascular hypertrophy by blocking AT receptor and reducing ET content in plasma and cardiovascular tissues.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2003年第1期32-34,共3页
Chinese Journal of New Drugs
关键词
氯沙坦
内皮素
左室肥厚
主动脉肥厚
losartan
ET
left ventricular hypertrophy
aortic hypertrophy